• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An Efficient, Noniterative Method of Identifying the Cost-Effectiveness Frontier.一种识别成本效益前沿的高效、非迭代方法。
Med Decis Making. 2016 Jan;36(1):132-6. doi: 10.1177/0272989X15583496. Epub 2015 Apr 29.
2
The Probabilistic Efficiency Frontier: A Framework for Cost-Effectiveness Analysis in Germany Put into Practice for Hepatitis C Treatment Options.概率效率前沿:德国成本效益分析框架在丙型肝炎治疗方案中的实际应用
Value Health. 2017 Feb;20(2):266-272. doi: 10.1016/j.jval.2016.12.015. Epub 2017 Feb 16.
3
Using propensity scores to estimate the cost-effectiveness of medical therapies.使用倾向评分来评估医学疗法的成本效益。
Stat Med. 2006 May 15;25(9):1561-76. doi: 10.1002/sim.2267.
4
Cost-effectiveness Analysis with Influence Diagrams.使用影响图的成本效益分析。
Methods Inf Med. 2015;54(4):353-8. doi: 10.3414/ME13-01-0121. Epub 2015 Mar 12.
5
Calculating and Interpreting ICERs and Net Benefit.计算和解释增量成本效果比(ICER)和净收益。
Pharmacoeconomics. 2020 Aug;38(8):785-807. doi: 10.1007/s40273-020-00914-6.
6
Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI).最优成本效益决策:成本效益可接受性曲线(CEAC)、成本效益可接受性前沿(CEAF)以及完美信息期望值(EVPI)的作用。
Value Health. 2008 Sep-Oct;11(5):886-97. doi: 10.1111/j.1524-4733.2008.00358.x. Epub 2008 May 16.
7
Health technology assessment in the cost-disutility plane.成本-效用平面中的卫生技术评估。
Med Decis Making. 2008 Mar-Apr;28(2):172-81. doi: 10.1177/0272989X07312474. Epub 2008 Mar 20.
8
Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease.成本效益模型的概率分析:胃食管反流病治疗策略的选择
Med Decis Making. 2002 Jul-Aug;22(4):290-308. doi: 10.1177/0272989X0202200408.
9
Clinical decision modeling system.临床决策建模系统。
BMC Med Inform Decis Mak. 2007 Aug 13;7:23. doi: 10.1186/1472-6947-7-23.
10
An efficient approach for optimizing the cost-effective individualized treatment rule using conditional random forest.利用条件随机森林优化具有成本效益的个体化治疗规则的有效方法。
Stat Methods Med Res. 2022 Nov;31(11):2122-2136. doi: 10.1177/09622802221115876. Epub 2022 Aug 1.

引用本文的文献

1
Identifying the population to be targeted in a lung cancer screening programme in Denmark.确定丹麦肺癌筛查计划中的目标人群。
BMJ Open Respir Res. 2024 Dec 25;11(1):e002499. doi: 10.1136/bmjresp-2024-002499.
2
Net Monetary Benefit Lines Augmented with Value-of-Information Measures to Present the Results of Economic Evaluations under Uncertainty.加入信息价值衡量指标的净货币效益线以呈现不确定性下经济评估的结果。
Med Decis Making. 2024 Oct;44(7):770-786. doi: 10.1177/0272989X241262343. Epub 2024 Jul 26.
3
Defining a Willingness-to-transplant Threshold in an Era of Organ Scarcity: Simultaneous Liver-kidney Transplant as a Case Example.在器官短缺时代定义移植意愿阈值:以肝肾联合移植为例。
Transplantation. 2020 Feb;104(2):387-394. doi: 10.1097/TP.0000000000002788.
4
Cost-Utility of Early Breast Cancer Surveillance in Survivors of Thoracic Radiation-Treated Adolescent Hodgkin Lymphoma.胸部放疗治疗的青少年霍奇金淋巴瘤幸存者的早期乳腺癌监测的成本-效用。
J Natl Cancer Inst. 2020 Jan 1;112(1):63-70. doi: 10.1093/jnci/djz037.
5
Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study.多学科护理治疗美国轻中度慢性肾脏病的成本效益:一项建模研究。
PLoS Med. 2018 Mar 27;15(3):e1002532. doi: 10.1371/journal.pmed.1002532. eCollection 2018 Mar.
6
Optimal timing of drug sensitivity testing for patients on first-line tuberculosis treatment.一线抗结核治疗患者药物敏感性检测的最佳时机。
Health Care Manag Sci. 2018 Dec;21(4):632-646. doi: 10.1007/s10729-017-9416-4. Epub 2017 Aug 31.
7
Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview.卫生经济评估决策分析模型的验证:概述
Pharmacoeconomics. 2017 Jul;35(7):673-683. doi: 10.1007/s40273-017-0508-2.

本文引用的文献

1
Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI).最优成本效益决策:成本效益可接受性曲线(CEAC)、成本效益可接受性前沿(CEAF)以及完美信息期望值(EVPI)的作用。
Value Health. 2008 Sep-Oct;11(5):886-97. doi: 10.1111/j.1524-4733.2008.00358.x. Epub 2008 May 16.
2
Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.人乳头瘤病毒DNA检测及HPV-16、18疫苗接种用于宫颈癌筛查的成本效益分析
J Natl Cancer Inst. 2008 Mar 5;100(5):308-20. doi: 10.1093/jnci/djn019. Epub 2008 Feb 26.

一种识别成本效益前沿的高效、非迭代方法。

An Efficient, Noniterative Method of Identifying the Cost-Effectiveness Frontier.

作者信息

Suen Sze-chuan, Goldhaber-Fiebert Jeremy D

机构信息

Department of Management Science and Engineering, Stanford University Stanford, CA, USA (SS)

Center for Health Policy and the Center for Primary Care and Outcomes Research, Stanford University, Stanford, CA, USA (JDG-F).

出版信息

Med Decis Making. 2016 Jan;36(1):132-6. doi: 10.1177/0272989X15583496. Epub 2015 Apr 29.

DOI:10.1177/0272989X15583496
PMID:25926282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4626430/
Abstract

Cost-effectiveness analysis aims to identify treatments and policies that maximize benefits subject to resource constraints. However, the conventional process of identifying the efficient frontier (i.e., the set of potentially cost-effective options) can be algorithmically inefficient, especially when considering a policy problem with many alternative options or when performing an extensive suite of sensitivity analyses for which the efficient frontier must be found for each. Here, we describe an alternative one-pass algorithm that is conceptually simple, easier to implement, and potentially faster for situations that challenge the conventional approach. Our algorithm accomplishes this by exploiting the relationship between the net monetary benefit and the cost-effectiveness plane. To facilitate further evaluation and use of this approach, we also provide scripts in R and Matlab that implement our method and can be used to identify efficient frontiers for any decision problem.

摘要

成本效益分析旨在确定在资源限制条件下使效益最大化的治疗方法和政策。然而,确定有效前沿(即一组潜在的成本效益选项)的传统过程在算法上可能效率低下,特别是在考虑有许多替代选项的政策问题时,或者在进行一系列广泛的敏感性分析时,每种分析都必须找到有效前沿。在这里,我们描述了一种替代的单遍算法,该算法概念简单,易于实现,并且在挑战传统方法的情况下可能更快。我们的算法通过利用净货币效益与成本效益平面之间的关系来实现这一点。为了便于对该方法进行进一步评估和使用,我们还提供了R和Matlab脚本,这些脚本实现了我们的方法,可用于识别任何决策问题的有效前沿。